$72.18

-0.78 (-1.07%)

Weekly Expected Move ±4.3%

$66 $69 $72 $75 $78

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $1.6B mcap · 19M float · 1.86% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

61.0 / 100

NoneWeakNarrowWide

Primary source: Network Effects · ROIC: 20.7% · 5Y Avg: -2.5%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ANIP has a Narrow competitive edge (61.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 20.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$85

Low

$100

Avg Target

$119

High

Based on 4 analysts since Aug 7, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 6Hold: 4Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$97.80

Analysts5

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-09-23	Oppenheimer	Les Sulewski	Initiated	$85	—	+9.1%	$77.91
2026-09-09	Leerink Partners	Daniel Clark	Initiated	$104	—	+47.9%	$70.32
2026-08-10	Guggenheim	Vamil Divan	$124	$119	-5	+52.1%	$78.25
2026-08-10	Canaccord Genuity	—	$91	$90	-1	+15.0%	$78.25
2026-07-16	Canaccord Genuity	—	Initiated	$91	—	+11.1%	$81.92
2026-01-16	Guggenheim	Vamil Divan	$114	$124	+10	+45.4%	$85.29
2025-10-09	Truist Financial	—	$60	$90	+30	-1.8%	$91.63
2025-09-17	H.C. Wainwright	Brandon Folkes	$94	$121	+27	+26.9%	$95.36
2025-09-08	Guggenheim	Vamil Divan	$86	$114	+28	+19.7%	$95.20
2025-08-08	Piper Sandler	David Amsellem	Initiated	$94	—	+15.9%	$81.13
2025-03-05	Guggenheim	—	Initiated	$86	—	+44.1%	$59.68
2024-09-18	Raymond James	Gary Nachman	$48	$83	+35	+35.6%	$61.23
2024-09-11	Truist Financial	Les Sulewski	Initiated	$60	—	+8.1%	$55.48
2024-06-26	H.C. Wainwright	Oren Livnat	$87	$94	+7	+43.5%	$65.49
2024-05-13	H.C. Wainwright	Oren Livnat	Initiated	$87	—	+27.8%	$68.06
2022-08-09	Raymond James	—	Initiated	$48	—	+37.7%	$34.87

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ANIP receives an overall rating of B. Strongest factors: ROE (4/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (1/5), P/B (2/5).

Rating Change History

Date	From	To
2026-08-28	B-	B
2026-08-14	B	B-
2026-07-25	B-	B
2026-07-01	B	B-
2026-05-06	B-	B
2026-04-30	B	B-
2026-04-01	B-	B
2026-02-27	C+	B-
2026-02-23	C	C+
2026-01-12	D+	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 73 Grade A

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

100

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ANIP scores highest in Momentum (100/100) and lowest in Profitability (59/100). An overall grade of A places ANIP among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.71

Grey Zone

Piotroski F-Score

7/9

✓ ✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓

Beneish M-Score

-2.56

Unlikely Manipulator

Ohlson O-Score

-7.87

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

A+

Score: 75.5/100

Trend: Improving

Earnings Quality

75/100

OCF/NI: 1.79x

Accruals: -5.9%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ANIP scores 2.71, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ANIP scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ANIP's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ANIP's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ANIP receives an estimated rating of A+ (score: 75.5/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ANIP's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

14.94x

PEG

0.01x

P/S

1.68x

P/B

2.56x

P/FCF

11.38x

P/OCF

9.57x

EV/EBITDA

6.91x

EV/Revenue

1.81x

EV/EBIT

10.40x

EV/FCF

11.09x

Earnings Yield

5.83%

FCF Yield

8.79%

Shareholder Yield

1.19%

Graham Number

$54.41

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 14.9x earnings, ANIP trades at a reasonable valuation. An earnings yield of 5.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $54.41 per share, 33% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.742

NI / EBT

Interest Burden

0.839

EBT / EBIT

EBIT Margin

0.174

EBIT / Rev

Asset Turnover

0.690

Rev / Assets

Equity Multiplier

2.680

Assets / Equity

ROE

20.0%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ANIP's ROE of 20.0% is driven by Asset Turnover (0.690), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$41.05

Price/Value

2.02x

Margin of Safety

-101.67%

Premium

101.67%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ANIP's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ANIP trades at a 102% premium to its adjusted intrinsic value of $41.05, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 14.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$72.18

Median 1Y

$62.49

5th Pctile

$26.97

95th Pctile

$144.74

Ann. Volatility

50.2%

Analyst Target

$97.80

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Nikhil Lalwani President and Chief Executive Officer	$837,409	$7,848,711	$10,278,620
Christopher K. Mutz Senior Vice President, Head of Rare Disease	$471,625	$2,130,319	$3,396,694
Stephen P. Carey Senior Vice President, Finance and Chief Financial Officer	$521,031	$2,130,319	$3,251,862
Meredith W. Cook Senior Vice President, General Counsel and Corporate Secretary	$462,052	$1,457,614	$2,318,421
Ori Gutwerg President, e President, Generics	$479,870	$1,345,411	$2,309,559

CEO Pay Ratio

31:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $10,278,620

Avg Employee Cost (SGA/emp): $327,572

Employees: 970

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

970

+8.1% YoY

Revenue / Employee

$910,687

Rev: $883,366,000

Profit / Employee

$80,760

NI: $78,337,000

SGA / Employee

$327,572

Avg labor cost proxy

R&D / Employee

$53,262

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-11.4%	-15.4%	-22.9%	-24.1%	-25.7%	-13.7%	-7.7%	-1.3%	3.4%	4.7%	8.7%	5.9%	-1.6%	-4.2%	-4.6%	-2.2%	8.1%	15.7%	17.8%	20.0%	19.99%
ROA	-4.7%	-6.9%	-10.4%	-10.3%	-11.2%	-6.3%	-3.5%	-0.6%	1.6%	2.3%	4.2%	3.0%	-0.7%	-1.7%	-1.9%	-0.9%	2.8%	5.6%	6.6%	7.5%	7.46%
ROIC	-3.3%	-5.8%	-8.8%	-8.4%	-8.5%	-4.8%	-0.9%	2.7%	7.8%	8.5%	9.0%	7.4%	1.0%	0.1%	0.6%	1.4%	8.3%	15.7%	17.0%	20.7%	20.68%
ROCE	-4.6%	-6.5%	-9.9%	-9.5%	-9.6%	-5.2%	-0.9%	2.6%	5.5%	6.2%	8.6%	7.3%	0.9%	-0.4%	-0.8%	0.4%	6.3%	11.6%	12.3%	14.0%	14.05%
Gross Margin	53.1%	44.4%	46.8%	52.2%	60.8%	61.5%	64.7%	63.7%	63.5%	59.4%	64.2%	58.2%	57.5%	57.9%	62.9%	64.7%	49.1%	96.2%	51.8%	62.4%	62.35%
Operating Margin	-6.8%	-38.9%	-29.8%	-17.5%	-6.0%	1.9%	9.3%	10.6%	13.6%	5.1%	14.8%	3.7%	-13.8%	-2.3%	13.3%	6.6%	10.0%	19.5%	16.3%	15.2%	15.21%
Net Margin	-8.5%	-39.6%	-31.2%	-20.2%	-10.3%	-4.5%	1.3%	5.4%	7.5%	0.9%	13.2%	-1.7%	-16.3%	-5.4%	8.0%	4.0%	10.6%	11.1%	12.4%	9.3%	9.29%
EBITDA Margin	12.9%	-20.9%	-7.3%	2.7%	12.4%	18.4%	23.0%	23.2%	25.1%	16.6%	32.5%	12.4%	-9.0%	7.8%	24.5%	18.6%	26.8%	31.1%	24.2%	22.7%	22.69%
FCF Margin	-7.3%	-9.4%	-27.1%	-20.9%	-18.6%	-15.1%	-2.1%	4.8%	11.8%	20.6%	18.4%	17.5%	13.4%	7.8%	7.3%	14.1%	16.4%	14.5%	17.4%	16.3%	16.30%
OCF Margin	4.6%	1.5%	-16.1%	-19.1%	-13.8%	-9.9%	2.6%	10.3%	15.5%	24.4%	22.4%	20.9%	16.7%	10.4%	12.0%	18.6%	20.6%	21.0%	22.6%	19.4%	19.37%
ROE 3Y Avg	snapshot only																				7.04%
ROE 5Y Avg	snapshot only																				0.21%
ROA 3Y Avg	snapshot only																				3.09%
ROIC 3Y Avg	snapshot only																				8.74%
ROIC Economic	snapshot only																				12.56%
Cash ROA	snapshot only																				12.68%
Cash ROIC	snapshot only																				34.34%
CROIC	snapshot only																				28.90%
NOPAT Margin	snapshot only																				11.66%
Pretax Margin	snapshot only																				14.57%
R&D / Revenue	snapshot only																				5.10%
SGA / Revenue	snapshot only																				33.19%
SBC / Revenue	snapshot only																				4.20%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-17.98	-15.34	-7.22	-7.59	-7.73	-13.71	-24.94	-186.30	82.98	56.43	37.77	45.54	-163.26	-58.03	-63.76	-129.76	50.73	22.09	18.48	17.14	14.944
P/S Ratio	1.87	3.02	2.01	1.92	1.85	2.08	1.83	2.39	2.47	2.18	2.59	2.28	2.08	1.75	1.99	1.77	2.34	1.90	1.79	1.85	1.677
P/B Ratio	2.08	1.82	1.31	1.43	1.56	1.94	1.93	2.21	2.44	2.32	2.82	2.56	2.69	2.51	3.03	2.87	3.82	3.10	2.95	3.04	2.557
P/FCF	-25.49	-32.18	-7.39	-9.20	-9.95	-13.78	-87.94	50.22	20.97	10.55	14.12	13.06	15.59	22.54	27.30	12.61	14.28	13.05	10.33	11.38	11.378
P/OCF	40.55	196.78	—	—	—	—	71.66	23.29	15.90	8.91	11.59	10.93	12.46	16.79	16.62	9.52	11.32	9.05	7.94	9.57	9.575
EV/EBITDA	21.70	269.82	-44.14	-81.02	-149.72	35.74	16.11	13.68	11.79	10.55	10.97	10.87	23.23	24.52	27.07	19.35	12.18	7.60	7.13	6.91	6.913
EV/Revenue	2.75	3.89	2.94	2.81	2.67	2.83	2.44	2.70	2.68	2.31	2.69	2.35	2.93	2.52	2.68	2.31	2.41	1.94	1.81	1.81	1.808
EV/EBIT	-33.28	-19.05	-10.07	-11.31	-12.01	-25.86	-160.05	57.04	28.72	24.02	20.78	22.29	165.79	-335.76	-199.44	381.23	27.59	12.77	11.52	10.40	10.402
EV/FCF	-37.46	-41.38	-10.82	-13.46	-14.32	-18.78	-117.20	56.72	22.73	11.19	14.62	13.46	21.94	32.45	36.82	16.40	14.72	13.35	10.44	11.09	11.092
Earnings Yield	-5.6%	-6.5%	-13.8%	-13.2%	-12.9%	-7.3%	-4.0%	-0.5%	1.2%	1.8%	2.6%	2.2%	-0.6%	-1.7%	-1.6%	-0.8%	2.0%	4.5%	5.4%	5.8%	5.83%
FCF Yield	-3.9%	-3.1%	-13.5%	-10.9%	-10.1%	-7.3%	-1.1%	2.0%	4.8%	9.5%	7.1%	7.7%	6.4%	4.4%	3.7%	7.9%	7.0%	7.7%	9.7%	8.8%	8.79%
PEG Ratio	snapshot only																				0.013
Price/Tangible Book	snapshot only																				21.374
EV/OCF	snapshot only																				9.335
EV/Gross Profit	snapshot only																				2.771
Acquirers Multiple	snapshot only																				11.777
Shareholder Yield	snapshot only																				1.19%
Graham Number	snapshot only																				$54.41

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	2.25	3.68	3.79	3.35	3.79	3.46	2.90	3.74	3.70	3.57	3.95	3.97	2.74	2.72	2.66	2.54	2.58	2.71	3.12	2.91	2.910
Quick Ratio	1.53	2.74	2.74	2.39	2.62	2.40	2.08	2.89	2.91	2.81	3.12	3.07	1.97	2.02	1.98	1.96	2.04	2.19	2.52	2.41	2.405
Debt/Equity	1.06	0.80	0.83	0.85	0.85	0.85	0.84	0.66	0.63	0.62	0.60	0.59	1.45	1.46	1.40	1.35	0.64	0.60	0.58	0.55	0.553
Net Debt/Equity	0.98	0.52	0.61	0.66	0.68	0.70	0.64	0.29	0.20	0.14	0.10	0.08	1.10	1.10	1.05	0.86	0.12	0.07	0.03	-0.08	-0.076
Debt/Assets	0.43	0.37	0.39	0.38	0.39	0.38	0.37	0.33	0.32	0.32	0.31	0.31	0.49	0.49	0.48	0.46	0.23	0.23	0.23	0.22	0.221
Debt/EBITDA	7.50	92.22	-19.09	-32.91	-56.90	11.44	5.27	3.61	2.80	2.68	2.25	2.44	8.91	9.89	9.32	6.98	1.97	1.44	1.40	1.29	1.291
Net Debt/EBITDA	6.94	60.04	-13.98	-25.64	-45.73	9.52	4.02	1.57	0.91	0.61	0.37	0.33	6.73	7.49	6.99	4.47	0.37	0.18	0.07	-0.18	-0.178
Interest Coverage	-1.75	-3.70	-4.10	-3.09	-2.51	-1.23	-0.19	0.64	1.46	1.74	2.81	2.66	0.57	-0.26	-0.43	0.18	2.67	3.06	4.54	6.20	6.198
Equity Multiplier	2.46	2.15	2.15	2.23	2.20	2.25	2.25	1.98	1.96	1.98	1.92	1.92	2.99	3.00	2.91	2.91	2.78	2.66	2.53	2.50	2.502
Cash Ratio	snapshot only																				1.325
Debt Service Coverage	snapshot only																				9.325
Cash to Debt	snapshot only																				1.138
FCF to Debt	snapshot only																				0.483
Defensive Interval	snapshot only																				486.4 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.46	0.35	0.37	0.41	0.47	0.41	0.48	0.50	0.55	0.58	0.62	0.61	0.51	0.56	0.61	0.66	0.61	0.65	0.68	0.69	0.690
Inventory Turnover	1.51	1.41	1.61	1.60	1.73	1.48	1.52	1.52	1.62	1.68	1.77	1.81	1.75	2.02	2.18	2.21	2.34	1.95	2.24	2.42	2.417
Receivables Turnover	2.23	1.93	2.02	2.07	2.29	2.15	2.34	2.48	2.82	2.97	2.98	3.18	2.96	3.20	3.43	3.82	3.68	3.51	3.88	3.91	3.913
Payables Turnover	7.31	5.88	6.41	6.30	8.94	5.31	5.20	5.32	6.20	5.50	4.70	5.40	4.70	6.08	5.35	5.64	5.26	5.05	5.13	5.30	5.299
DSO	164	189	180	176	159	170	156	147	130	123	122	115	123	114	106	96	99	104	94	93	93.3 days
DIO	242	258	227	229	211	246	240	241	225	218	206	201	208	181	167	165	156	187	163	151	151.0 days
DPO	50	62	57	58	41	69	70	69	59	66	78	68	78	60	68	65	69	72	71	69	68.9 days
Cash Conversion Cycle	355	386	351	347	329	347	325	319	296	274	250	248	254	235	205	196	186	219	186	175	175.4 days
Fixed Asset Turnover	snapshot only																				13.362
Operating Cycle	snapshot only																				244.3 days
Cash Velocity	snapshot only																				2.603
Capital Intensity	snapshot only																				1.527

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	6.7%	3.7%	6.0%	17.8%	33.2%	46.4%	58.6%	59.7%	58.8%	53.9%	44.3%	34.3%	23.6%	26.2%	30.3%	38.7%	48.9%	43.8%	37.0%	30.9%	30.90%
Net Income	6.9%	-88.9%	-3.1%	-2.7%	-2.1%	-12.4%	58.1%	91.9%	1.2%	1.4%	2.4%	6.2%	-1.5%	-2.0%	-1.6%	-1.4%	6.4%	5.1%	5.3%	11.4%	11.36%
EPS	7.7%	-59.8%	-2.0%	-1.7%	-1.3%	2.3%	59.1%	92.6%	1.2%	1.3%	2.1%	5.8%	-1.5%	-2.0%	-1.6%	-1.4%	5.9%	4.8%	5.0%	10.6%	10.60%
FCF	63.0%	61.7%	-3.7%	-2.1%	-2.4%	-1.3%	87.8%	1.4%	2.0%	3.1%	13.7%	3.9%	40.3%	-52.5%	-48.3%	11.5%	82.2%	1.7%	2.3%	51.7%	51.72%
EBITDA	23.2%	-88.9%	-1.4%	-1.3%	-1.2%	7.0%	4.6%	10.1%	21.3%	3.3%	1.3%	47.1%	-31.3%	-40.8%	-47.2%	-23.7%	1.3%	2.6%	2.5%	1.9%	1.87%
Op. Income	25.1%	-1.5%	-11.1%	-5.3%	-2.9%	11.3%	90.0%	1.3%	1.7%	2.3%	10.3%	1.6%	-72.2%	-98.8%	-88.7%	-69.7%	4.0%	189.2%	18.1%	8.9%	8.89%
OCF Growth	snapshot only																				36.17%
Asset Growth	snapshot only																				11.25%
Equity Growth	snapshot only																				29.38%
Debt Growth	snapshot only																				-46.85%
Shares Change	snapshot only																				7.91%
Dividend Growth	snapshot only																				-80.38%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	3.5%	2.4%	2.8%	5.3%	9.5%	15.3%	20.8%	26.7%	31.2%	32.7%	34.4%	36.2%	37.8%	41.7%	43.9%	43.8%	42.9%	40.8%	37.1%	34.6%	34.58%
Revenue 5Y	14.4%	10.9%	9.3%	9.7%	11.0%	12.3%	14.0%	16.2%	18.6%	19.3%	20.0%	20.2%	20.8%	24.4%	27.1%	30.5%	32.9%	33.5%	34.1%	35.6%	35.60%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	88.9%	-5.6%	9.8%	-0.1%	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	1.1%	4.1%	21.3%	9.3%	—	—	—	—	—	—	—	—	—
EBITDA 3Y	-24.8%	-64.3%	—	—	—	-25.6%	7.5%	47.5%	67.2%	55.9%	49.1%	50.6%	37.6%	1.7%	—	—	—	1.1%	62.9%	47.7%	47.74%
EBITDA 5Y	-9.8%	-41.0%	—	—	—	-15.0%	-1.9%	5.4%	10.0%	9.2%	11.3%	8.5%	-1.5%	0.8%	8.9%	29.2%	49.6%	51.7%	43.8%	49.6%	49.61%
Gross Profit 3Y	0.8%	-3.5%	-7.6%	-6.1%	-0.8%	7.4%	17.6%	27.3%	33.9%	36.0%	36.4%	37.8%	39.9%	46.6%	53.2%	54.6%	48.8%	50.9%	41.2%	36.3%	36.28%
Gross Profit 5Y	10.7%	7.7%	6.0%	7.2%	9.7%	12.7%	15.9%	18.0%	19.2%	18.9%	18.2%	17.3%	17.2%	20.5%	24.6%	30.1%	32.4%	38.1%	36.6%	38.2%	38.24%
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	98.8%	98.77%
Op. Income 5Y	—	—	—	—	—	—	—	-8.9%	6.1%	5.8%	11.6%	7.3%	-18.5%	-48.6%	9.5%	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	61.2%	—	—	—	—	—	—	—	—	1.0%	1.03%
FCF 5Y	—	—	—	—	—	—	—	42.3%	—	12.3%	26.4%	27.5%	12.7%	21.9%	—	—	—	—	47.8%	—	—
OCF 3Y	-44.0%	-63.3%	—	—	—	—	-34.8%	-5.7%	39.4%	98.3%	50.1%	1.0%	1.1%	1.7%	—	—	—	—	1.8%	66.2%	66.20%
OCF 5Y	-13.4%	-34.5%	—	—	—	—	-30.3%	-8.5%	4.6%	12.1%	14.7%	15.6%	6.4%	7.0%	19.6%	23.1%	45.9%	64.7%	43.5%	69.4%	69.39%
Assets 3Y	2.3%	21.5%	19.7%	18.9%	17.4%	18.5%	16.6%	22.7%	24.4%	25.2%	25.4%	24.2%	39.9%	18.5%	20.2%	21.4%	24.0%	23.7%	22.9%	20.2%	20.25%
Assets 5Y	8.1%	19.0%	15.8%	15.9%	14.8%	13.0%	12.9%	15.2%	15.2%	16.0%	16.1%	15.6%	23.0%	23.0%	21.8%	23.6%	24.9%	25.6%	25.1%	25.5%	25.49%
Equity 3Y	-0.2%	22.1%	20.1%	17.5%	16.5%	16.7%	19.1%	31.4%	32.6%	32.7%	32.8%	35.8%	31.1%	6.1%	8.6%	11.1%	14.5%	16.9%	18.3%	11.2%	11.19%
Book Value 3Y	-1.0%	14.7%	8.3%	7.0%	5.4%	5.0%	6.7%	15.0%	13.5%	13.4%	13.1%	16.1%	12.0%	-4.5%	1.0%	3.2%	5.1%	7.1%	8.3%	3.8%	3.85%
Dividend 3Y	—	—	—	—	—	84.0%	25.3%	2.8%	-10.2%	-14.5%	-14.8%	-14.5%	-14.6%	-10.0%	-7.0%	-7.1%	-9.4%	-18.2%	-29.2%	-44.3%	-44.34%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.74	0.79	0.84	0.81	0.72	0.67	0.62	0.64	0.66	0.66	0.70	0.74	0.79	0.83	0.86	0.89	0.89	0.91	0.94	0.95	0.955
Earnings Stability	0.53	0.58	0.59	0.66	0.72	0.79	0.55	0.27	0.10	0.09	0.00	0.01	0.01	0.00	0.02	0.20	0.41	0.52	0.50	0.58	0.576
Margin Stability	0.92	0.90	0.88	0.87	0.88	0.89	0.89	0.91	0.92	0.93	0.89	0.88	0.89	0.90	0.90	0.90	0.93	0.92	0.96	0.96	0.964
Rev. Growth Consistency	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.500
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.50	0.50	0.95	0.50	0.50	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.200
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	-0.09	-0.08	-0.14	-0.09	-0.08	-0.02	0.05	0.13	0.19	0.17	0.20	0.16	0.07	0.01	-0.05	-0.04	0.07	0.14	0.15	0.16	0.160
Gross Margin Trend	-0.08	-0.10	-0.14	-0.11	-0.07	0.00	0.06	0.09	0.09	0.08	0.08	0.05	0.02	-0.00	-0.02	-0.01	-0.03	0.08	0.05	0.04	0.040
FCF Margin Trend	-0.06	-0.01	-0.25	-0.13	-0.04	0.02	0.06	0.19	0.25	0.33	0.33	0.26	0.17	0.05	-0.01	0.03	0.04	0.00	0.05	0.01	0.005
Sustainable Growth Rate	—	—	—	—	—	—	—	—	3.0%	4.3%	8.3%	5.5%	—	—	—	—	7.8%	15.4%	17.7%	19.9%	19.92%
Internal Growth Rate	—	—	—	—	—	—	—	—	1.5%	2.1%	4.2%	2.9%	—	—	—	—	2.8%	5.8%	7.0%	8.0%	8.03%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	-0.44	-0.08	0.58	0.75	0.58	0.65	-0.35	-8.00	5.22	6.33	3.26	4.17	-13.10	-3.46	-3.84	-13.62	4.48	2.44	2.33	1.79	1.790
FCF/OCF	-1.59	-6.12	1.69	1.09	1.35	1.53	-0.81	0.46	0.76	0.84	0.82	0.84	0.80	0.75	0.61	0.76	0.79	0.69	0.77	0.84	0.842
FCF/Net Income	snapshot only																				1.507
OCF/EBITDA	snapshot only																				0.741
CapEx/Revenue	12.0%	10.9%	11.1%	1.8%	4.8%	5.2%	4.6%	5.5%	3.8%	3.8%	4.0%	3.4%	3.4%	2.7%	4.7%	4.6%	4.3%	6.4%	5.2%	3.1%	3.07%
CapEx/Depreciation	snapshot only																				0.350
Accruals Ratio	-0.07	-0.07	-0.04	-0.03	-0.05	-0.02	-0.05	-0.06	-0.07	-0.12	-0.10	-0.10	-0.09	-0.08	-0.09	-0.13	-0.10	-0.08	-0.09	-0.06	-0.059
Sloan Accruals	snapshot only																				0.064
Cash Flow Adequacy	snapshot only																				6.239
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.1%	0.2%	0.3%	0.2%	0.2%	0.2%	0.1%	0.2%	0.1%	0.1%	0.1%	0.2%	0.1%	0.1%	0.1%	0.1%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.01	$0.04	$0.06	$0.09	$0.10	$0.10	$0.09	$0.09	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.08	$0.07	$0.05	$0.03	$0.02	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	12.2%	8.7%	4.6%	6.0%	—	—	—	—	4.1%	1.5%	0.8%	0.3%	0.33%
FCF Payout Ratio	—	—	—	—	—	—	—	8.5%	3.1%	1.6%	1.7%	1.7%	2.2%	3.4%	3.3%	1.5%	1.2%	0.9%	0.5%	0.2%	0.22%
Total Payout Ratio	—	—	—	—	—	—	—	—	43.6%	31.6%	31.1%	43.7%	—	—	—	—	31.2%	15.5%	23.6%	20.3%	20.34%
Div. Increase Streak	—	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0
Chowder Number	—	—	—	—	—	7.56	1.74	0.62	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.04	-0.29	-0.54	-0.79	-0.788
Buyback Yield	0.2%	0.1%	0.4%	0.3%	0.4%	0.3%	0.7%	0.5%	0.4%	0.4%	0.7%	0.8%	0.9%	1.0%	0.9%	0.8%	0.5%	0.6%	1.2%	1.2%	1.17%
Net Buyback Yield	0.2%	-14.6%	-20.9%	-19.6%	-18.0%	0.3%	0.7%	-8.1%	-7.0%	-7.3%	-5.4%	0.7%	0.9%	0.8%	0.7%	0.7%	0.4%	0.6%	1.1%	1.0%	1.03%
Total Shareholder Return	0.2%	-14.6%	-20.7%	-19.4%	-17.8%	0.5%	0.9%	-7.9%	-6.8%	-7.2%	-5.3%	0.9%	1.0%	0.9%	0.8%	0.8%	0.5%	0.7%	1.1%	1.0%	1.05%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.80	0.76	0.77	0.77	0.77	0.76	0.76	0.49	1.01	0.94	0.83	0.76	0.95	0.83	0.76	0.69	0.75	0.79	0.77	0.74	0.742
Interest Burden (EBT/EBIT)	1.57	1.27	1.24	1.32	1.40	1.81	6.33	-0.55	0.31	0.42	0.64	0.62	-0.76	4.82	3.04	-3.26	0.70	0.71	0.80	0.84	0.839
EBIT Margin	-0.08	-0.20	-0.29	-0.25	-0.22	-0.11	-0.02	0.05	0.09	0.10	0.13	0.11	0.02	-0.01	-0.01	0.01	0.09	0.15	0.16	0.17	0.174
Asset Turnover	0.46	0.35	0.37	0.41	0.47	0.41	0.48	0.50	0.55	0.58	0.62	0.61	0.51	0.56	0.61	0.66	0.61	0.65	0.68	0.69	0.690
Equity Multiplier	2.41	2.22	2.20	2.33	2.29	2.20	2.20	2.09	2.06	2.09	2.06	1.95	2.46	2.47	2.40	2.40	2.88	2.81	2.70	2.68	2.680

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-1.83	$-3.00	$-3.89	$-3.91	$-4.16	$-2.93	$-1.59	$-0.29	$0.70	$0.98	$1.83	$1.40	$-0.37	$-0.95	$-1.05	$-0.50	$1.81	$3.57	$4.16	$4.83	$4.83
Book Value/Share	$15.81	$25.29	$21.45	$20.71	$20.65	$20.74	$20.54	$24.33	$23.78	$23.81	$24.55	$24.88	$22.20	$22.04	$22.12	$22.73	$23.98	$25.47	$26.10	$27.25	$28.23
Tangible Book/Share	$1.46	$2.59	$2.25	$2.41	$2.71	$3.59	$4.38	$9.85	$10.81	$11.47	$13.00	$13.94	$-10.28	$-8.91	$-7.77	$-5.87	$-2.68	$-0.06	$1.52	$3.87	$3.87
Revenue/Share	$17.55	$15.24	$14.01	$15.45	$17.36	$19.38	$21.70	$22.48	$23.50	$25.33	$26.64	$27.89	$28.63	$31.60	$33.63	$36.80	$39.20	$41.61	$42.88	$44.64	$46.24
FCF/Share	$-1.29	$-1.43	$-3.80	$-3.22	$-3.23	$-2.92	$-0.45	$1.07	$2.77	$5.23	$4.89	$4.88	$3.83	$2.45	$2.45	$5.17	$6.42	$6.05	$7.44	$7.28	$7.54
OCF/Share	$0.81	$0.23	$-2.25	$-2.95	$-2.39	$-1.91	$0.55	$2.31	$3.65	$6.19	$5.96	$5.83	$4.79	$3.29	$4.03	$6.85	$8.09	$8.73	$9.68	$8.65	$8.95
Cash/Share	$1.26	$7.07	$4.77	$3.90	$3.45	$2.95	$4.10	$9.06	$10.10	$11.51	$12.27	$12.79	$7.90	$7.77	$7.74	$11.01	$12.45	$13.45	$14.44	$17.15	$17.76
EBITDA/Share	$2.22	$0.22	$-0.93	$-0.54	$-0.31	$1.53	$3.29	$4.44	$5.34	$5.55	$6.52	$6.04	$3.62	$3.25	$3.34	$4.38	$7.76	$10.63	$10.89	$11.67	$11.67
Debt/Share	$16.68	$20.26	$17.79	$17.63	$17.59	$17.55	$17.32	$16.02	$14.95	$14.86	$14.70	$14.76	$32.23	$32.10	$31.07	$30.61	$15.30	$15.32	$15.21	$15.07	$15.07
Net Debt/Share	$15.42	$13.19	$13.03	$13.74	$14.14	$14.60	$13.22	$6.97	$4.85	$3.36	$2.43	$1.98	$24.33	$24.32	$23.33	$19.60	$2.85	$1.87	$0.77	$-2.08	$-2.08

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.708
Altman Z-Prime	snapshot only																				5.335
Piotroski F-Score	5	4	3	3	5	3	6	7	7	7	7	7	3	3	3	4	6	7	7	7	7
Beneish M-Score	-2.50	-2.37	-2.04	-1.94	-2.24	-2.37	-2.44	-2.56	-2.49	-2.94	-2.89	-2.95	-2.55	-2.15	-2.27	-2.38	-2.48	-2.83	-2.63	-2.56	-2.557
Ohlson O-Score	snapshot only																				-7.866
ROIC (Greenblatt)	snapshot only																				27.65%
Net-Net WC	snapshot only																				$-3.26
EVA	snapshot only																				$58896674.64

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				A+
Credit Score	27.40	30.26	35.11	35.28	36.15	31.82	33.76	47.30	57.34	62.25	70.11	65.11	34.98	31.41	30.12	35.38	59.57	64.23	70.20	75.51	75.509
Credit Grade	snapshot only																				5
Credit Trend	snapshot only																				40.128
Implied Spread (bps)	snapshot only																				125.000
Industry Credit Rank	snapshot only																				68
Sector Credit Rank	snapshot only																				75

ANIP NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet